PharmaTelevision - DuBiotech: The Creation of a Knowledge-based Economy

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: DuBiotech: The Creation of a Knowledge-based Economy

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this latest interview, Fintan Walton talks with Dr Ihsan Almarzouqi at BIO San Diego. They discuss the innovative development currently under construction in Dubai - the Dubai Biotechnology and Research Park (DuBiotech).

Dr Almarzouqi explains that the Park was set up as part of the Dubai government’s vision to diversify their economy. So far, they have attracted 45 major companies including big pharmaceuticals, such as Amgen and Pfizer, and their goal is to attract companies from every aspect of the industry including legal, logistical and biotech support services. Ihsan Almarzouqi describes the unique opportunities that Dubai offers because of its location and the support available to companies interested in investing in the future of this venture.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Origins and aims of DuBiotech

Fintan Walton:

Hello and welcome to PharmaVentures Business Review here in San Diego, California. On this show I have Dr Ihsan Almarzouqi, who is the Director of Business Development at DuBiotech. Welcome to the show.

Ihsan Almarzouqi:

Thank you.

Fintan Walton:

Ihsan, the DuBiotech is a now relatively good name around the world, people are learning about DuBiotech, could you tell us a little bit about the origins of DuBiotech and the aims of that company?

Ihsan Almarzouqi:

Sure. Well the Dubai Biotechnology and Research Park short for DuBiotech was launched about three-years ago as by the ruler of Dubai as part of a 2010 and now 2015 strategy of the city of Dubai, The Emirate of Dubai to diversify from it's, from your that's your typical oil based economy to a knowledge based economy. So three components where identified healthcare, education and biotechnology and the first two are fairly advanced in their implementation in Dubai and the third biotechnology falls under DuBiotech to let's say drive the biotech industry, an industry that wasn't really existent as a five-years ago.

Fintan Walton:

Sure.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Ihsan Almarzouqi

Director of Business Development

Dr Ihsan Almarzouqi is the Director of Business Development for the Dubai Biotechnology and Research Park (DuBiotech). In this position he is responsible for all investment activities in biotechnology and life sciences on behalf of DuBiotech, TECOM Investments and Dubai Holding, its parent companies. Before taking up his present role he was a project manager for DuBiotech, looking after all the infrastructure and construction related investments for the park. Dr Almarzouqi is on the board of several committees of life science organizations in the UAE, and is leading 14 special-status scientific projects that are considered crucial to the development of the biotechnology industry in the UAE. IhsanAlmarzouqi obtained his PhD and Masters in Biochemical Engineering from University College London. He holds a degree in Chemical Engineering from the University of Sheffield and is currently working towards an Executive MBA from London Business School.

DuBiotech

Dubai Biotechnology and Research Park (DuBiotech) is the Middle East's first Science and Business Park dedicated to the international life science industry. It was officially launched in February 2005 by His Highness Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President and Prime Minister and Ruler of Dubai as part of Dubai's 2010 vision to establish a knowledge-based economy. DuBiotech, upon completion, will cover 30 million square feet of built-up area. It is located in a prime area of Dubai and the Park is divided into zones that are dedicated to various initiatives and companies of all sizes from across the life science industry with an overall focus on research and development. To date, DuBiotech has attracted several key players in the Biotechnology and Pharmaceutical industries, as well as entrepreneurs, drug manufacturers, and industry specific business support services. It is also actively building affiliations and alliances with universities, specialist hospitals, world regulatory bodies and other research parks to link the DuBiotech community with the global biotechnology industry.